Jul 1 |
Verrica Pharmaceuticals Settles Cantharidin-Related Lawsuit With Dormer Labs
|
Jul 1 |
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
|
Jun 28 |
High Insider Ownership Growth Stocks On US Exchange For June 2024
|
Jun 27 |
Recent 12% pullback would hurt Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders
|
May 30 |
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
|
May 30 |
High Insider Ownership Growth Companies On US Exchange May 2024
|
May 15 |
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
|
May 14 |
Verrica Pharmaceuticals Inc (VRCA) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
May 13 |
Verrica Pharmaceuticals, Inc. (VRCA) Q1 2024 Earnings Call Transcript
|
May 13 |
Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2024 Results: A Detailed Financial Review
|